News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,127 Results
Type
Article (42376)
Company Profile (277)
Press Release (684464)
Multimedia
Podcasts (82)
Webinars (18)
Section
Business (205901)
Career Advice (2082)
Deals (35707)
Drug Delivery (111)
Drug Development (81554)
Employer Resources (175)
FDA (16471)
Job Trends (15091)
News (348199)
Policy (32942)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2650)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49991)
ALS (170)
Alzheimer's disease (1674)
Antibody-drug conjugate (ADC) (311)
Approvals (16734)
Artificial intelligence (529)
Autoimmune disease (157)
Automation (40)
Bankruptcy (364)
Best Places to Work (11693)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (177)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (642)
Cancer (4818)
Cardiovascular disease (399)
Career advice (1762)
Career pathing (36)
CAR-T (282)
CDC (45)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69639)
Collaboration (1721)
Company closure (4)
Compensation (1162)
Complete response letters (56)
COVID-19 (2744)
CRISPR (91)
C-suite (848)
Cystic fibrosis (143)
Data (6241)
Decentralized trials (2)
Denatured (26)
Depression (131)
Diabetes (500)
Diagnostics (6812)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (260)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90365)
Editorial (57)
Employer branding (22)
Employer resources (154)
Events (117861)
Executive appointments (980)
FDA (19591)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1479)
Gene editing (197)
Generative AI (45)
Gene therapy (601)
GLP-1 (973)
Government (4692)
Grass and pollen (6)
Guidances (383)
Healthcare (18976)
HIV (60)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (251)
Immuno-oncology (57)
Indications (110)
Infectious disease (3016)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (250)
Interviews (321)
IPO (16683)
IRA (50)
Job creations (3729)
Job search strategy (1477)
JPM (57)
Kidney cancer (16)
Labor market (87)
Layoffs (554)
Leadership (35)
Legal (7997)
Liver cancer (91)
Longevity (15)
Lung cancer (649)
Lymphoma (376)
Machine learning (43)
Management (59)
Manufacturing (797)
MASH (163)
Medical device (13851)
Medtech (13905)
Mergers & acquisitions (20098)
Metabolic disorders (1268)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (316)
Neuropsychiatric disorders (88)
Neuroscience (2911)
Neurotech (1)
NextGen: Class of 2026 (6584)
Non-profit (4563)
Now hiring (67)
Obesity (596)
Opinion (267)
Ovarian cancer (166)
Pain (199)
Pancreatic cancer (227)
Parkinson's disease (283)
Partnered (33)
Patents (496)
Patient recruitment (489)
Peanut (56)
People (59267)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21709)
Phase 2 (30651)
Phase 3 (22832)
Pipeline (5299)
Policy (283)
Postmarket research (2570)
Preclinical (9241)
Press Release (68)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (836)
Real estate (6098)
Recruiting (71)
Regulatory (24640)
Reports (53)
Research institute (2464)
Resumes & cover letters (356)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (149)
Series A (240)
Series B (191)
Service/supplier (13)
Sickle cell disease (96)
Special edition (23)
Spinal muscular atrophy (157)
Sponsored (43)
Startups (3669)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1010)
Venture capital (89)
Weight loss (380)
Women's health (91)
Worklife (19)
Date
Today (29)
Last 7 days (553)
Last 30 days (2047)
Last 365 days (29946)
2026 (3489)
2025 (30311)
2024 (35363)
2023 (40251)
2022 (51417)
2021 (55934)
2020 (54410)
2019 (46899)
2018 (35247)
2017 (32446)
2016 (31873)
2015 (37854)
2014 (31618)
2013 (26710)
2012 (28894)
2011 (29577)
2010 (27546)
Location
Africa (758)
Alabama (83)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (39672)
Australia (6462)
California (11329)
Canada (3299)
China (1109)
Colorado (478)
Connecticut (478)
Delaware (337)
Europe (85397)
Florida (1691)
Georgia (363)
Hawaii (3)
Idaho (62)
Illinois (862)
India (65)
Indiana (525)
Iowa (23)
Japan (432)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1383)
Massachusetts (8119)
Michigan (324)
Minnesota (631)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3012)
New Mexico (29)
New York (2994)
North Carolina (1454)
North Dakota (9)
Northern California (5527)
Ohio (343)
Oklahoma (21)
Oregon (41)
Pennsylvania (2280)
Puerto Rico (24)
Rhode Island (48)
South America (1132)
South Carolina (66)
South Dakota (1)
Southern California (4415)
Tennessee (174)
Texas (1746)
United States (40172)
Utah (340)
Vermont (1)
Virginia (263)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
727,127 Results for "geovax labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
HHS Pulls Funding for GeoVax’s Next-Gen COVID-19 Vaccine
GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb development.
April 17, 2025
·
2 min read
·
Tristan Manalac
Policy
GeoVax Announces Multiple Patent Issuances and Allowances
GeoVax Labs, Inc. announced multiple actions by global patent offices strengthening the Company’s intellectual property assets.
February 13, 2024
·
5 min read
Press Releases
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
November 19, 2025
·
1 min read
BioMidwest
Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
GeoVax Labs, Inc. announced the presentation of preclinical vaccine efficacy data for GEO-CM02, a multi-antigen investigational SARS-CoV-2 vaccine.
November 14, 2023
·
7 min read
Press Releases
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 15, 2025
December 16, 2025
·
1 min read
BioMidwest
GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
GeoVax Labs, Inc., a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced an update on key strategic initiatives.
October 24, 2023
·
6 min read
BioMidwest
GeoVax to Participate in Upcoming November 2023 Investor and Industry Events
GeoVax Labs, Inc. announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November.
October 25, 2023
·
3 min read
GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it will participate in the Alliance Global Partners’ Virtual Healthcare Conference being held May 23-24, 2023.
May 9, 2023
·
1 min read
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Press Releases
Registration is Now Open for Tribe Public’s Webinar Event “Now Is Not the Time to Monkey(pox) Around” Featuring GeoVax Lab’s CEO
August 22, 2024
·
3 min read
1 of 72,713
Next
